Alnylam Pharmaceuticals Depreciation & Amortization 2011-2026 | ALNY

Annual Depreciation & Amortization Alnylam Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
55.7 M	56.7 M	54.1 M	44.5 M	47.6 M	34.8 M	17.2 M	15.2 M	13.4 M	15.1 M	19 M	11.9 M	10.2 M	9.04 M	5.12 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
56.7 M	5.12 M	27.3 M

Quarterly Depreciation & Amortization Alnylam Pharmaceuticals

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	14.4 M	-	-	-	13.5 M	-	-	-	14.1 M	-	30.2 M	-	9.46 M	-	36.2 M	-	12.6 M	-	24.4 M	15.8 M	7.61 M	-	11.7 M	7.69 M	3.84 M	-	5.82 M	5.42 M	3.18 M	-	9.65 M	6.07 M	3 M	-	12.1 M	8.61 M	4.6 M	-	14 M	8.71 M	3.69 M	-	8.58 M	5.47 M	2.6 M	-	7.6 M	4.84 M	2.13 M	-	7.01 M	4.73 M	2.12 M	-	3.89 M	2.63 M	1.34 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.2 M	1.34 M	9.17 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Aligos Therapeutics ALGS	930 K	$ 8.74	0.23 %	$ 86.4 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.38	0.09 %	$ 999 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.56	6.12 %	$ 401 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.05	4.45 %	$ 5.02 M	Israel
Aquestive Therapeutics AQST	548 K	$ 4.15	-0.95 %	$ 444 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 25.09	4.02 %	$ 3.19 B	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.48	0.68 %	$ 394 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Cabaletta Bio CABA	1.65 M	$ 3.26	1.87 %	$ 328 M	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 4.63	9.01 %	$ 312 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA